Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Hôpital Européen Marseille clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France register with Hôpital Européen Marseille as lead sponsor. Synced 14 Nov 2026
9Current trials
8Recruiting now
0Drugs in these trials
1Trial register
At a glance

Hôpital Européen Marseille is the lead sponsor of 9 current clinical trials in our France register. 8 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is HIV Infections.

ClinicalTrials.gov trials by status

  • Recruiting889%
  • Active, closed111%

Trials by phase

  • Not applicable556%
  • Observational444%
01

Clinical trials sponsored by Hôpital Européen Marseille

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Impact of Onco-sexology Support on the Quality of Life of Patients Newly Diagnosed for Cancer
NCT06332573 · ClinicalTrials.gov ↗ · Cancer
Not applicable Recruiting 2025-04 France
Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy
NCT05303337 · ClinicalTrials.gov ↗ · HIV Infections
Observational Recruiting 2022-04 France
Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
NCT04132206 · ClinicalTrials.gov ↗ · Systemic Sclerosis
Observational Recruiting 2019-10 France
Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy
NCT04899154 · ClinicalTrials.gov ↗ · Spondyloarthritis
Not applicable Recruiting 2019-07 France
Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service
NCT07422077 · ClinicalTrials.gov ↗ · Stress Disorders, Post-Traumatic
Not applicable Recruiting 2025-12 France
Is Post-exertional Symptom Exacerbation Specific to Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome? A Study Comparing Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome and Patients With Cardiac Diseases Who Underwent an Exercise Test.
NCT07491315 · ClinicalTrials.gov ↗ · Fatigue Syndrome, Chronic, Cardiovascular Diseases
Not applicable Recruiting 2025-06 France
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 · ClinicalTrials.gov ↗ · Migraine Disorders
Not applicable Recruiting 2025-05 France
Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIV
NCT05078957 · ClinicalTrials.gov ↗ · HIV Infections
Observational Recruiting 2023-12 France
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
NCT04987528 · ClinicalTrials.gov ↗ · Severe Acute Respiratory Syndrome Coronavirus 2, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
Observational Active, closed 2020-03 France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Hôpital Européen Marseille trials

11 conditions
HIV Infections2Cancer1Severe Acute Respiratory Syndrome Coronavirus 21Acute Respiratory Distress Syndrome1Pulmonary Fibrosis1Systemic Sclerosis1Spondyloarthritis1Stress Disorders, Post-Traumatic1Fatigue Syndrome, Chronic1Cardiovascular Diseases1Migraine Disorders1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in France98

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in HIV Infections

SponsorTrials
ViiV Healthcare20
Oswaldo Cruz Foundation3
Kirby Institute2
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida2
PENTA Foundation1
Memorial University of Newfoundland1
José Antonio Mata Marín1

Sponsors with the most current trials registered for this condition.

05

Questions about Hôpital Européen Marseille trials

How many clinical trials does Hôpital Européen Marseille sponsor?

Hôpital Européen Marseille is the lead sponsor of 9 current trials on ClinicalTrials.gov in our France register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are Hôpital Européen Marseille trials recruiting?

Yes. 8 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.